The comprehensive in Vitro Fibrillation assay (CiF) is a non-clinical, mechanism-based methodology for testing cardiovascular risk. This is the first assay to determine electrophysiological and endoribic acid responses in cloned human cardiac arrhythmias. The second strand of the CIPA assay measures changes inricular output, conduction, frequency and wave form. The third strand measures electrophysiological parameters, […]
Read More